Figures & data
Table 1. Patient demographic and clinical characteristics.
Table 2. Significant risk factors for all-cause mortality and CV events.
Figure 2. Cumulative incidence curves for mortality and CV events by category of the use of PPI. (A) Cumulative incidence curves for all-cause mortality. (B) Cumulative incidence curves for the incidence of CV events. The curves were constructed using the Kaplan–Meier method and compared using the Mantel–Cox log-rank test.
![Figure 2. Cumulative incidence curves for mortality and CV events by category of the use of PPI. (A) Cumulative incidence curves for all-cause mortality. (B) Cumulative incidence curves for the incidence of CV events. The curves were constructed using the Kaplan–Meier method and compared using the Mantel–Cox log-rank test.](/cms/asset/99a8b329-f6c5-4c82-97d9-61eb1841a651/irnf_a_2043903_f0002_c.jpg)
Figure 3. Cumulative incidence curves for mortality and CV events by category of the usage of PPI after IPTW. (A) Cumulative incidence curves for all-cause survival. (B) Cumulative incidence curves for the incidence of CV events. The curves were constructed using the Kaplan–Meier method and compared using the Mantel–Cox log-rank test.
![Figure 3. Cumulative incidence curves for mortality and CV events by category of the usage of PPI after IPTW. (A) Cumulative incidence curves for all-cause survival. (B) Cumulative incidence curves for the incidence of CV events. The curves were constructed using the Kaplan–Meier method and compared using the Mantel–Cox log-rank test.](/cms/asset/004cb7ec-62a4-43ff-9b33-a318daea49b1/irnf_a_2043903_f0003_c.jpg)
Table 3. Relationship between PPI and the adverse prognosis.